Evidence suggests ARBs should be first line for CV indications over ACE inhibitors (<a href="http://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.120.16667">Chen et al. <em>Hypertension</em> 2021</a>). Which ARBs should you choose when prescribing?

<table><thead><tr><th colspan="1" rowspan="1" align="left">When?</th>
<th colspan="2" rowspan="1" align="left">Which one to give?</th>
<th colspan="1" rowspan="1" align="left">Which one to avoid?</th>
</tr><tr><th colspan="1" rowspan="1" align="left">Clinical condition of concern</th>
<th colspan="1" rowspan="1" align="left">First ARBs of choice</th>
<th colspan="1" rowspan="1" align="left">ARBs with potentially beneficial effects</th>
<th colspan="1" rowspan="1" align="left">ARBs with potentially negative effect</th>
</tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left">Cardiovascular prevention</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-10" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR10" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">10</a>–<a id="bkmrk-12" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR12" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">12</a>]</td>
<td colspan="1" rowspan="1" align="left">Losartan [<a id="bkmrk-13" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR13" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">13</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Heart failure</td>
<td colspan="1" rowspan="1" align="left">Valsartan [<a id="bkmrk-14" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR14" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">14</a>]<br>Candesartan [<a id="bkmrk-15" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR15" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">15</a>, <a id="bkmrk-16" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR16" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">16</a>]<br>Losartan [<a id="bkmrk-17" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR17" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">17</a>–<a id="bkmrk-19" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR19" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">19</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Myocardial infarction</td>
<td colspan="1" rowspan="1" align="left">Valsartan [<a id="bkmrk-20" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR20" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">20</a>, <a id="bkmrk-21" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR21" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">21</a>]</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-10-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR10" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">10</a>, <a id="bkmrk-22" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR22" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">22</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Stroke</td>
<td colspan="1" rowspan="1" align="left">Losartan [<a id="bkmrk-23" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR23" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">23</a>]</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-24" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR24" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">24</a>, <a id="bkmrk-25" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR25" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">25</a>]<br>Candesartan [<a id="bkmrk-27" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR27" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">27</a>]<br>Eprosartan [<a id="bkmrk-28" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR28" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">28</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Atrial fibrillation</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-34" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR34" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">34</a>–<a class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR36" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">36</a>]</td>
<td colspan="1" rowspan="1" align="left">Losartan [<a id="bkmrk-29" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR29" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">29</a>, <a id="bkmrk-33" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR33" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">33</a>]<br>Candesartan [<a id="bkmrk-30" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR30" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">30</a>]<br>Valsartan [<a id="bkmrk-31" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR31" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">31</a>, <a id="bkmrk-32" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR32" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">32</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Diabetes mellitus</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-47" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR47" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">47</a>, <a id="bkmrk-50" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR50" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">50</a>, <a id="bkmrk-54" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR54" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">54</a>, <a id="bkmrk-55" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR55" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">55</a>]<br>Valsartan [<a id="bkmrk-47-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR47" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">47</a>, <a id="bkmrk-53" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR53" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">53</a>, <a id="bkmrk-55-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR55" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">55</a>]</td>
<td colspan="1" rowspan="1" align="left">Losartan [<a id="bkmrk-47-1" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR47" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">47</a>, <a id="bkmrk-53-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR53" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">53</a>]<br>Irbesartan [<a id="bkmrk-47-2" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR47" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">47</a>]<br>Candesartan [<a id="bkmrk-47-3" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR47" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">47</a>, <a id="bkmrk-53-1" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR53" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">53</a>]</td>
<td colspan="1" rowspan="1" align="left">Olmesartan [<a id="bkmrk-47-4" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR47" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">47</a>]</td>
</tr><tr><td colspan="1" rowspan="1" align="left">Diabetic nephropathy</td>
<td colspan="1" rowspan="1" align="left">Losartan [<a id="bkmrk-60" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR60" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">60</a>]<br>Irbesartan [<a id="bkmrk-61" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR61" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">61</a>, <a id="bkmrk-62" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR62" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">62</a>]</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-63" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR63" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">63</a>]<br>Valsartan [<a id="bkmrk-64" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR64" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">64</a>–<a id="bkmrk-66" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR66" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">66</a>]<br>Candesartan [<a id="bkmrk-67" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR67" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">67</a>]</td>
<td colspan="1" rowspan="1" align="left">Olmesartan [<a id="bkmrk-68" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR68" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">68</a>–<a id="bkmrk-70" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR70" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">70</a>]</td>
</tr><tr><td colspan="1" rowspan="1" align="left">Metabolic syndrome</td>
<td colspan="1" rowspan="1" align="left">Telmisartan [<a id="bkmrk-72" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR72" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">72</a>, <a id="bkmrk-75" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR75" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">75</a>, <a id="bkmrk-77" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR77" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">77</a>–<a id="bkmrk-79" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR79" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">79</a>]</td>
<td colspan="1" rowspan="1" align="left">Valsartan [<a id="bkmrk-81" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR81" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">81</a>, <a id="bkmrk-82" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR82" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">82</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Hyperuricemia</td>
<td colspan="1" rowspan="1" align="left">Losartan [<a id="bkmrk-89" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR89" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">89</a>–<a id="bkmrk-91" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR91" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">91</a>]</td>
<td colspan="1" rowspan="1" align="left">Irbesartan [<a id="bkmrk-93" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR93" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">93</a>]</td>
<td colspan="1" rowspan="1" align="left">Candesartan [<a id="bkmrk-89-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR89" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">89</a>–<a id="bkmrk-91-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR91" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">91</a>]</td>
</tr><tr><td colspan="1" rowspan="1" align="left">Erectile dysfunction</td>
<td colspan="1" rowspan="1" align="left">Valsartan [<a id="bkmrk-101" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR101" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">101</a>–<a id="bkmrk-104" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR104" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">104</a>]<br>Losartan [<a id="bkmrk-105" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR105" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">105</a>, <a id="bkmrk-106" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR106" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">106</a>]<br>Irbesartan [<a id="bkmrk-106-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR106" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">106</a>, <a id="bkmrk-108" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR108" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">108</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr><tr><td colspan="1" rowspan="1" align="left">Cognitive decline</td>
<td colspan="1" rowspan="1" align="left"> </td>
<td colspan="1" rowspan="1" align="left">Candesartan [<a id="bkmrk-116" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR116" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">116</a>]<br>Irbesartan [<a id="bkmrk-116-0" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR116" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">116</a>]<br>Losartan [<a id="bkmrk-116-1" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR116" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">116</a>]<br>Valsartan [<a id="bkmrk-116-2" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR116" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">116</a>]<br>Eprosartan [<a id="bkmrk-121" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR121" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">121</a>]<br>Telmisartan [<a id="bkmrk-122" class=" bibr" role="button" href="https://www-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca/pmc/articles/PMC4947116/#CR122" target="_blank" rel="noopener" aria-expanded="false" aria-haspopup="true">122</a>]</td>
<td colspan="1" rowspan="1" align="left"> </td>
</tr></tbody></table><h2 id="bkmrk-pharmacology">Pharmacology</h2>
<main id="bkmrk-arbs-half-life-%28h%29-t" class="usa-grid usa-layout-docs pmc-main"><article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article"><section role="document"><div>
<div data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'">
<div>
<div>
<div>
<table><thead><tr><th colspan="1" rowspan="1" align="left">ARBs</th>
<th colspan="1" rowspan="1">Half-life (h)</th>
<th colspan="1" rowspan="1">Tmax (h)</th>
<th colspan="1" rowspan="1">Bioavailability</th>
<th colspan="1" rowspan="1">Route of elimination: renal (R)<br>biliary/fecal (B)</th>
<th colspan="1" rowspan="1">Food Interaction</th>
<th colspan="1" rowspan="1">Drug Interactions<sup>ϕ</sup></th>
<th colspan="1" rowspan="1">CYP metabolism</th>
</tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left"><strong>Losartan</strong><sup>*</sup></td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">1–1.5</td>
<td colspan="1" rowspan="1">33%</td>
<td colspan="1" rowspan="1">35% R; 60% B</td>
<td colspan="1" rowspan="1">Yes<sup>∞</sup></td>
<td colspan="1" rowspan="1">Rifampin, fluconazole</td>
<td colspan="1" rowspan="1">2C9, 3A4</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Candesartan cilexetil</strong></td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">2–5<sup>ε</sup></td>
<td colspan="1" rowspan="1">42%</td>
<td colspan="1" rowspan="1">33% R; 67% B</td>
<td colspan="1" rowspan="1">No</td>
<td colspan="1" rowspan="1">None</td>
<td colspan="1" rowspan="1">2C9 (negligible)</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Eprosartan</strong></td>
<td colspan="1" rowspan="1">5–9</td>
<td colspan="1" rowspan="1">1–3</td>
<td colspan="1" rowspan="1">63%</td>
<td colspan="1" rowspan="1">7% R; 90% B</td>
<td colspan="1" rowspan="1">Yes<sup>¶</sup></td>
<td colspan="1" rowspan="1">None</td>
<td colspan="1" rowspan="1">No</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Irbesartan</strong></td>
<td colspan="1" rowspan="1">11–15</td>
<td colspan="1" rowspan="1">1.3–3</td>
<td colspan="1" rowspan="1">60–80%</td>
<td colspan="1" rowspan="1">20% R; 80% B</td>
<td colspan="1" rowspan="1">No</td>
<td colspan="1" rowspan="1"> </td>
<td colspan="1" rowspan="1">2C9, 3A4 (negligible)</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Telmisartan</strong></td>
<td colspan="1" rowspan="1">24</td>
<td colspan="1" rowspan="1">0.5–1</td>
<td colspan="1" rowspan="1">43%</td>
<td colspan="1" rowspan="1">&lt;1% R; &gt;97% B</td>
<td colspan="1" rowspan="1">No</td>
<td colspan="1" rowspan="1">Digoxin</td>
<td colspan="1" rowspan="1">No</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Valsartan</strong></td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">2–4</td>
<td colspan="1" rowspan="1">23% (capsule)<br>50% (solution)</td>
<td colspan="1" rowspan="1">13% R; 83% B</td>
<td colspan="1" rowspan="1">Yes<sup>§</sup></td>
<td colspan="1" rowspan="1">None</td>
<td colspan="1" rowspan="1">2C9 (weak)</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Olmesartan medoxomil</strong></td>
<td colspan="1" rowspan="1">12–14</td>
<td colspan="1" rowspan="1">1.7–2.5</td>
<td colspan="1" rowspan="1">26%</td>
<td colspan="1" rowspan="1">35–50%R; 50–65% B</td>
<td colspan="1" rowspan="1">No</td>
<td colspan="1" rowspan="1">None</td>
<td colspan="1" rowspan="1">No</td>
</tr><tr><td colspan="1" rowspan="1" align="left"><strong>Azilsartan medoxomil</strong></td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">1.5–3</td>
<td colspan="1" rowspan="1">60%</td>
<td colspan="1" rowspan="1">42% urine; 55% B</td>
<td colspan="1" rowspan="1">No</td>
<td colspan="1" rowspan="1">None</td>
<td colspan="1" rowspan="1">2C9, CYP2B6 (negligible), CYP2C8 (negligible)</td>
</tr></tbody></table></div>
</div>
</div>
</div>
</div>
</section></article></main><h2 id="bkmrk-references">References</h2>
<ol id="bkmrk-https%3A%2F%2Fmedsask.usas"><li><a href="https://medsask.usask.ca/documents/drug-shortages-pdfs/arb-comparison-.v22.pdf">https://medsask.usask.ca/documents/drug-shortages-pdfs/arb-comparison-.v22.pdf</a></li>
<li>Dézsi CA. The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? <em>Am J Cardiovasc Drugs</em>. 2016;16:255-266. doi:<a href="https://doi.org/10.1007/s40256-016-0165-4">10.1007/s40256-016-0165-4</a></li>
<li>Abraham HMA, White CM, White WB. The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of [[Hypertension]] and Other Cardiovascular Diseases. <em>Drug Saf</em>. 2015;38(1):33-54. doi:<a href="https://doi.org/10.1007/s40264-014-0239-7">10.1007/s40264-014-0239-7</a></li>
</ol>